BACKGROUND: Human cardiac progenitor cells (hCPCs) may promote myocardial regeneration in adult ischemic myocardium. The regenerative capacity of hCPCs in young patients with nonischemic congenital heart defects for potential use in congenital heart defect repair warrants exploration. METHODS AND RESULTS: Human right atrial specimens were obtained during routine congenital cardiac surgery across 3 groups: neonates (age, <30 days), infants (age, 1 month to 2 years), and children (age, >2 to ≤13 years). C-kit(+) hCPCs were 3-fold higher in neonates than in children >2 years of age. hCPC proliferation was greatest during the neonatal period as evidenced by c-kit(+) Ki67(+) expression but decreased with age. hCPC differentiation capacity was also greatest in neonatal right atrium as evidenced by c-kit(+), NKX2-5(+), NOTCH1(+), and NUMB(+) expression. Despite the age-dependent decline in resident hCPCs, we isolated and expanded right atrium-derived CPCs from all patients (n=103) across all ages and diagnoses using the cardiosphere method. Intact cardiospheres contained a mix of heart-derived cell subpopulations that included cardiac progenitor cells expressing c-kit(+), Islet-1, and supporting cells. The number of c-kit(+)-expressing cells was highest in human cardiosphere-derived cells (hCDCs) grown from neonatal and infant right atrium. Furthermore, hCDCs could differentiate into diverse cardiovascular lineages by in vitro differentiation assays. Transplanted hCDCs promoted greater myocardial regeneration and functional improvement in infarcted myocardium than transplanted cardiac fibroblasts. CONCLUSIONS: Resident hCPCs are most abundant in the neonatal period and rapidly decrease over time. hCDCs can be reproducibly isolated and expanded from young human myocardial samples regardless of age or diagnosis. hCPCs are functional and have potential in congenital cardiac repair.
BACKGROUND:Human cardiac progenitor cells (hCPCs) may promote myocardial regeneration in adult ischemic myocardium. The regenerative capacity of hCPCs in young patients with nonischemic congenital heart defects for potential use in congenital heart defect repair warrants exploration. METHODS AND RESULTS:Human right atrial specimens were obtained during routine congenital cardiac surgery across 3 groups: neonates (age, <30 days), infants (age, 1 month to 2 years), and children (age, >2 to ≤13 years). C-kit(+) hCPCs were 3-fold higher in neonates than in children >2 years of age. hCPC proliferation was greatest during the neonatal period as evidenced by c-kit(+) Ki67(+) expression but decreased with age. hCPC differentiation capacity was also greatest in neonatal right atrium as evidenced by c-kit(+), NKX2-5(+), NOTCH1(+), and NUMB(+) expression. Despite the age-dependent decline in resident hCPCs, we isolated and expanded right atrium-derived CPCs from all patients (n=103) across all ages and diagnoses using the cardiosphere method. Intact cardiospheres contained a mix of heart-derived cell subpopulations that included cardiac progenitor cells expressing c-kit(+), Islet-1, and supporting cells. The number of c-kit(+)-expressing cells was highest in humancardiosphere-derived cells (hCDCs) grown from neonatal and infant right atrium. Furthermore, hCDCs could differentiate into diverse cardiovascular lineages by in vitro differentiation assays. Transplanted hCDCs promoted greater myocardial regeneration and functional improvement in infarcted myocardium than transplanted cardiac fibroblasts. CONCLUSIONS: Resident hCPCs are most abundant in the neonatal period and rapidly decrease over time. hCDCs can be reproducibly isolated and expanded from young human myocardial samples regardless of age or diagnosis. hCPCs are functional and have potential in congenital cardiac repair.
Authors: Harald C Ott; Thomas S Matthiesen; Johannes Brechtken; Suzanne Grindle; Saik-Kia Goh; Wendy Nelson; Doris A Taylor Journal: Nat Clin Pract Cardiovasc Med Date: 2007-02
Authors: Wangde Dai; Sharon L Hale; Bradley J Martin; Jin-Qiang Kuang; Joan S Dow; Loren E Wold; Robert A Kloner Journal: Circulation Date: 2005-07-05 Impact factor: 29.690
Authors: Claudia Bearzi; Marcello Rota; Toru Hosoda; Jochen Tillmanns; Angelo Nascimbene; Antonella De Angelis; Saori Yasuzawa-Amano; Irina Trofimova; Robert W Siggins; Nicole Lecapitaine; Stefano Cascapera; Antonio P Beltrami; David A D'Alessandro; Elias Zias; Federico Quaini; Konrad Urbanek; Robert E Michler; Roberto Bolli; Jan Kajstura; Annarosa Leri; Piero Anversa Journal: Proc Natl Acad Sci U S A Date: 2007-08-20 Impact factor: 11.205
Authors: Padmini Sirish; Javier E López; Ning Li; Andrew Wong; Valeriy Timofeyev; J Nilas Young; Maryam Majdi; Ronald A Li; Huei-Sheng Vincent Chen; Nipavan Chiamvimonvat Journal: J Mol Cell Cardiol Date: 2011-10-20 Impact factor: 5.000
Authors: Mathias H Konstandin; Haruhiro Toko; Grady M Gastelum; Pearl Quijada; Andrea De La Torre; Mercedes Quintana; Brett Collins; Shabana Din; Daniele Avitabile; Mirko Völkers; Natalie Gude; Reinhard Fässler; Mark A Sussman Journal: Circ Res Date: 2013-05-07 Impact factor: 17.367
Authors: Yang Gao; Jennifer Petsche Connell; Lalita Wadhwa; Rodrigo Ruano; Jeffrey G Jacot Journal: Ann Biomed Eng Date: 2014-09-30 Impact factor: 3.934
Authors: Philip D Tatman; Kathleen C Woulfe; Anis Karimpour-Fard; Danielle A Jeffrey; James Jaggers; Joseph C Cleveland; Karin Nunley; Matthew Rg Taylor; Shelley D Miyamoto; Brian L Stauffer; Carmen C Sucharov Journal: JCI Insight Date: 2017-07-20
Authors: Xuwei Hou; Nancy Appleby; Tania Fuentes; Lawrence D Longo; Leonard L Bailey; Nahidh Hasaniya; Mary Kearns-Jonker Journal: J Clin Exp Cardiolog Date: 2012-10-11